Stock ELDN ELEDON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eledon Pharmaceuticals, Inc.

Equities

ELDN

US28617K1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.02 USD +2.54% Intraday chart for Eledon Pharmaceuticals, Inc. +1.51% +12.22%
Mar. 28 Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 25 Eledon Pharmaceuticals Says 12th Participant Enrolled in Tegoprubart Trial; Shares Rise After Hours MT

Evolution of the average Target Price on Eledon Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0f038d0843ae68cff7c348e19b5f8.HLbNOJbqMwEVQ-BatwWWM7Ei96dCKcX-noqHBarb66A.V86GW_3dWkVTAo431HzbWoVDreITUJqN-s3uSt_pgfF9m4ZT1KNDbyIkkw~f1cd6a81c347a94282e08123db7ea7b3

Analyst Recommendations on Eledon Pharmaceuticals, Inc.

Noble Capital Initiates Coverage on Eledon Pharmaceuticals with Outperform Rating, $10 Price Target MT
SVB Securities LLC Adjusts Price Target for Eledon Pharmaceuticals to $26 From $33, Reiterates Outperform Rating MT
HC Wainwright Adjusts Eledon Pharmaceuticals' Price Target to $25 From $35, Keeps Buy Rating MT
ELEDON PHARMACEUTICALS : SVB Leerink Adjusts Price Target on Eledon Pharmaceuticals to $33 From $34, Maintains Outperform Rating MT
ELEDON PHARMACEUTICALS : Cantor Fitzgerald Starts Eledon Pharmaceuticals at Overweight With $25 Price Target MT
ELEDON PHARMACEUTICALS : SVB Leerink Starts Eledon Pharmaceuticals at Outperform With $34 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.02 USD
Average target price
15.6 USD
Spread / Average Target
+672.28%
High Price Target
39 USD
Spread / Highest target
+1,830.69%
Low Price Target
7 USD
Spread / Lowest Target
+246.53%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eledon Pharmaceuticals, Inc.

Noble Capital
SVB Securities LLC
HC Wainwright
SVB Leerink
Cantor Fitzgerald

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ELDN Stock
  4. Consensus Eledon Pharmaceuticals, Inc.